Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
Oncol Rep
    December 2025
  1. ZHENG WW, Ding JX, Liang YX, Ye L, et al
    Hydroxypropyl?beta?cyclodextrin/thymoquinone inclusion complex inhibits non?small cell lung cancer progression through NF?kappaB?mediated ferroptosis.
    Oncol Rep. 2025;54:157.
    >> Share

  2. ZHAO C, Xu Y, Zhang Y, Tan W, et al
    [Expression of Concern] Downregulation of miR?145 contributes to lung adenocarcinoma cell growth to form brain metastases.
    Oncol Rep. 2025;54:158.
    >> Share

    November 2025
  3. LEI Y, Guo W, Chen B, Chen L, et al
    [Retracted] Tumor?released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non?small cell lung cancer.
    Oncol Rep. 2025;54:140.
    >> Share

  4. WU A, Ni Y, Zhou Y, Shi J, et al
    Emerging dual role of ferroptosis in lung cancer (Review).
    Oncol Rep. 2025;54:141.
    >> Share

  5. TANG C, Hahm E, Bae S, Kang JS, et al
    [Expression of Concern] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin?related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
    Oncol Rep. 2025;54:146.
    >> Share

  6. WU X, Qu C, Ouyang Y, Yang L, et al
    T cell exhaustion?related gene CD79B predicts prognosis, inhibits malignant progression and promotes tumor?associated macrophage M1?like polarization in lung adenocarcinoma.
    Oncol Rep. 2025;54:144.
    >> Share

  7. LV Q, Xu J, Hu N, Zhao Y, et al
    Lactylation modification in lung cancer: A review of current research and future directions (Review).
    Oncol Rep. 2025;54:148.
    >> Share

    October 2025
  8. LIN Z, Chen Q, Chen Z, Peng T, et al
    Advances in the chemo?preventive effects and mechanisms of ursolic acid against lung cancer (Review).
    Oncol Rep. 2025;54:126.
    >> Share

  9. FUJIYOSHI K, Sugihara R, Miyamoto N, Watanabe Y, et al
    Comprehensive genetic profiling using tissue and blood in locally advanced tumors.
    Oncol Rep. 2025;54:134.
    >> Share

    September 2025
  10. DU J, Gong X, Huang R, Zheng B, et al
    Harnessing CRISPR/Cas9 to overcome targeted therapy resistance in non?small cell lung cancer: Advances and challenges (Review).
    Oncol Rep. 2025;54:111.
    >> Share

  11. KIM MS, Kim MS
    TRPML3?mediated lysosomal Ca(2+) release enhances drug sequestration and biogenesis, promoting osimertinib resistance in non?small cell lung cancer.
    Oncol Rep. 2025;54:113.
    >> Share

    August 2025
  12. ZINNAH KMA, Park SY
    [Corrigendum] Sensitizing TRAIL?resistant A549 lung cancer cells and enhancing TRAIL?induced apoptosis with the antidepressant amitriptyline.
    Oncol Rep. 2025;54:87.
    >> Share

    July 2025
  13. YAN Y, Kong X, Jin X, Bu J, et al
    RNA?binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor immunity in lung adenocarcinoma by controlling the expression of tumor suppressor RNF125.
    Oncol Rep. 2025;54:74.
    >> Share

    June 2025
  14. YUAN Q, Li X, Chen X, Xiao J, et al
    7?Difluoromethoxyl?5,4'?di?n?octylygenistein targets the STAT3 pathway by upregulating microRNA?152?3p expression to inhibit self?renewal and tumor growth in non?small cell lung carcinoma.
    Oncol Rep. 2025;53:66.
    >> Share

    May 2025
  15. HU Y, Liu X, Yuan Z, He J, et al
    Induction of necroptosis in lung adenocarcinoma by miR?10b?5p through modulation of the PKP3/RIPK3/MLKL cascade.
    Oncol Rep. 2025;53:56.
    >> Share

  16. LIN GB, Chen WT, Kuo YY, Liu HH, et al
    Thermal cycling?hyperthermia sensitizes non?small cell lung cancer A549 cells to EGFR tyrosine kinase inhibitor erlotinib.
    Oncol Rep. 2025;53:58.
    >> Share

  17. ZHANG J, Qi S, Du Y, Dai H, et al
    Effect of quercetin on inhibiting gefitinib?activated non?small cell lung cancer?induced cell pyroptosis in cardiomyocytes via modulating mitochondrial autophagy mediated by the SHP2/ROS/AMPK/XBP?1/DJ?1 signaling pathway.
    Oncol Rep. 2025;53:57.
    >> Share

    April 2025
  18. ZHANG L, Wang S, Wang L
    Pan?cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma.
    Oncol Rep. 2025;53:50.
    >> Share

    February 2025
  19. PENG Y, Li D, Wampfler JA, Luo YH, et al
    Targeted therapy?associated cardiotoxicity in patients with stage?IV lung cancer with or without cardiac comorbidities.
    Oncol Rep. 2025;53:25.
    >> Share

  20. ZHOU S, Sun J, Zhu W, Yang Z, et al
    Hypoxia studies in non?small cell lung cancer: Pathogenesis and clinical implications (Review).
    Oncol Rep. 2025;53:29.
    >> Share

    January 2025
  21. MUTO S, Homma MK, Kiko Y, Ozaki Y, et al
    Nucleolar casein kinase 2 alpha as a prognostic factor in patients with surgically resected early?stage lung adenocarcinoma.
    Oncol Rep. 2025;53:4.
    >> Share

  22. WANG M, Chen X, Fu G, Ge M, et al
    [Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS?mutated lung cancer cells.
    Oncol Rep. 2025;53:1.
    >> Share

    December 2024
  23. WEI Q, Lin J, Lin Z, Yu N, et al
    GOLPH3 inhibition overcomes cisplatin resistance by restoring the glutathione/reactive oxygen species balance in the A549 non?small cell lung cancer cell line.
    Oncol Rep. 2024;52:170.
    >> Share

  24. HU X, Zhang S, Zhang X, Liu H, et al
    HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation.
    Oncol Rep. 2024;52:173.
    >> Share

    November 2024
  25. GUI H, Nie Y, Yuan H, Jing Q, et al
    The combination of a PTP1B inhibitor, TNFR2 blocker, and PD?1 antibody suppresses the progression of non?small cell lung cancer tumors by enhancing immunocompetence.
    Oncol Rep. 2024;52:149.
    >> Share

  26. KANAYAMA M, Yoneda K, Kuwata T, Mori M, et al
    Enhanced capture system for mesenchymal?type circulating tumor cells using a polymeric microfluidic device 'CTC?Chip' incorporating cell?surface vimentin.
    Oncol Rep. 2024;52:156.
    >> Share

  27. GEORGAKOPOULOU VE, Lempesis IG, Trakas N, Sklapani P, et al
    Lung cancer and obesity: A contentious relationship (Review).
    Oncol Rep. 2024;52:158.
    >> Share

    October 2024
  28. ZHOU M, Wei L, Lu R
    Emerging role of sirtuins in non?small cell lung cancer (Review).
    Oncol Rep. 2024;52:127.
    >> Share

  29. WEI W, Zhao X, Zhu J, Zhang L, et al
    [Retracted] lncRNA?u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
    Oncol Rep. 2024;52:126.
    >> Share

  30. MUNKHJARGAL B, Kondo K, Soejima S, Tegshee B, et al
    DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma.
    Oncol Rep. 2024;52:131.
    >> Share

    August 2024
  31. LI S, Wang H, Ma R, Wang L, et al
    [Retracted] Schisandrin B inhibits epithelial?mesenchymal transition and stemness of large?cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF?kappaB and p38 MAPK signaling pathways.
    Oncol Rep. 2024;52:102.
    >> Share

    July 2024
  32. CHENG SH, Tu KY, Lee HH
    The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review).
    Oncol Rep. 2024;52:96.
    >> Share

    June 2024
  33. GAO Y, Zhang G, Liu J, Li H, et al
    [Retracted] Tissue?specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA?125a?5p in lung cancer.
    Oncol Rep. 2024;51:76.
    >> Share

    February 2024
  34. ZHANG F, Qi Y, Li J, Liu B, et al
    Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway.
    Oncol Rep. 2024;51:29.
    >> Share

  35. LU X, Ma S, Li Y, Pan Y, et al
    Identification of ITGB4 as a novel tumor promoting gene in lung adenocarcinoma (LUAD).
    Oncol Rep. 2024;51:30.
    >> Share

  36. LOU H, Wu Z, Wei G
    CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses.
    Oncol Rep. 2024;51:35.
    >> Share

    January 2024
  37. CHENG Z, Cui H, Wang Y, Yang J, et al
    The advance of the third?generation EGFR?TKI in the treatment of non?small cell lung cancer (Review).
    Oncol Rep. 2024;51:16.
    >> Share

    December 2023
  38. LIU J, Zhang F, Wang J, Wang Y, et al
    MicroRNA?mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).
    Oncol Rep. 2023;50:211.
    >> Share

    November 2023
  39. CHEN Z, Li P, Shen L, Jiang X, et al
    Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by inhibiting glycolysis.
    Oncol Rep. 2023;50:196.
    >> Share

  40. WU Z, Liu S, Pang G, Jiang H, et al
    RNA?binding protein quaking 5 inhibits the progression of non?small cell lung cancer by upregulating netrin?4 expression.
    Oncol Rep. 2023;50:204.
    >> Share

  41. TIAN C, Li J, Ren L, Peng R, et al
    [Retracted] MicroRNA?381 serves as a prognostic factor and inhibits migration and invasion in non?small cell lung cancer by targeting LRH?1.
    Oncol Rep. 2023;50:203.
    >> Share

  42. ZHANG J, Darman L, Hassan MS, Von Holzen U, et al
    Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review).
    Oncol Rep. 2023;50:206.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016